Literature DB >> 19415462

Altered gene and protein expression by Nm23-H1 in metastasis suppression.

Jong Heun Lee1, Jean-Claude Marshall, Patricia S Steeg, Christine E Horak.   

Abstract

Metastasis suppressor genes (MSG) are characterized by their ability to inhibit the formation of metastasis, while not affecting the growth of the primary tumor in vivo. Nm23-H1, the first MSG to be characterized, has been shown to alter both gene and protein expression in cancer cells. Recently, microarray expression profiling revealed that Nm23-H1 downregulated EDG2, which encodes for a lysophosphatidic acid (LPA) receptor. Reintroduction of EDG2 into cells that express Nm23-H1 overcame the metastasis suppressive ability of Nm23-H1 in both in vivo pulmonary colonization and spontaneous metastasis assays. In addition, isotope capture affinity tag (ICAT) proteomic analysis was performed to identify differentially expressed proteins not accounted for by microarray analysis. ICAT identified several differentially regulated proteins, including GEMIN5, a protein involved in differential mRNA splicing. The contribution of alternative mRNA splicing to cancer and cancer metastasis is poorly defined. It is possible that Nm23-H1, through the regulation of RNA processing proteins, may play a role in proteome stability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415462      PMCID: PMC3514412          DOI: 10.1007/s11010-009-0124-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  50 in total

1.  Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.

Authors:  H Miyazaki; M Fukuda; Y Ishijima; Y Takagi; T Iimura; A Negishi; R Hirayama; N Ishikawa; T Amagasa; N Kimura
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

Review 2.  Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application.

Authors:  Carrie W Rinker-Schaeffer; James P O'Keefe; Danny R Welch; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

Review 3.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

4.  Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene.

Authors:  Claudia Ghigna; Silvia Giordano; Haihong Shen; Federica Benvenuto; Fabio Castiglioni; Paolo Maria Comoglio; Michael R Green; Silvano Riva; Giuseppe Biamonti
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

5.  Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.

Authors:  Kwan-Sik Kim; Saubhik Sengupta; Michael Berk; Yong-Geun Kwak; Pedro F Escobar; Jerome Belinson; Samuel C Mok; Yan Xu
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

6.  Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma.

Authors:  Mathieu Boissan; Dominique Wendum; Sandrine Arnaud-Dabernat; Annie Munier; Marcel Debray; Ioan Lascu; Jean-Yves Daniel; Marie-Lise Lacombe
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

7.  Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro.

Authors:  Z M Bhujwalla; E O Aboagye; R J Gillies; V P Chacko; C E Mendola; J M Backer
Journal:  Magn Reson Med       Date:  1999-05       Impact factor: 4.668

8.  Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells.

Authors:  Massimiliano Salerno; Diane Palmieri; Amina Bouadis; Douglas Halverson; Patricia S Steeg
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

9.  Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells.

Authors:  Dai Shida; Joji Kitayama; Hironori Yamaguchi; Hiroharu Yamashita; Ken Mori; Toshiaki Watanabe; Hirokazu Nagawa
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

10.  Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines.

Authors:  R L Russell; A N Pedersen; J Kantor; K Geisinger; R Long; N Zbieranski; A Townsend; B Shelton; N Brünner; T E Kute
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

View more
  11 in total

1.  Nucleoside diphosphate kinase B knock-out mice have impaired activation of the K+ channel KCa3.1, resulting in defective T cell activation.

Authors:  Lie Di; Shekhar Srivastava; Olga Zhdanova; Yi Sun; Zhai Li; Edward Y Skolnik
Journal:  J Biol Chem       Date:  2010-09-30       Impact factor: 5.157

Review 2.  Learning about the functions of NME/NM23: lessons from knockout mice to silencing strategies.

Authors:  Mathieu Boissan; Marie-Lise Lacombe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-12       Impact factor: 3.000

3.  Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells.

Authors:  Maria I Almeida; Milena S Nicoloso; Lizhi Zeng; Cristina Ivan; Riccardo Spizzo; Roberta Gafà; Lianchun Xiao; Xinna Zhang; Ivan Vannini; Francesca Fanini; Muller Fabbri; Giovanni Lanza; Rui M Reis; Patrick A Zweidler-McKay; George A Calin
Journal:  Gastroenterology       Date:  2012-01-10       Impact factor: 22.682

Review 4.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

5.  Mechanisms of non-metastatic 2 (NME2)-mediated control of metastasis across tumor types.

Authors:  Ram Krishna Thakur; Vinod Kumar Yadav; Pankaj Kumar; Shantanu Chowdhury
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-10       Impact factor: 3.000

Review 6.  NM23/NDPK proteins in transcription regulatory functions and chromatin modulation: emerging trends.

Authors:  Shalu Sharma; Antara Sengupta; Shantanu Chowdhury
Journal:  Lab Invest       Date:  2017-10-30       Impact factor: 5.662

Review 7.  Gemin5: A Multitasking RNA-Binding Protein Involved in Translation Control.

Authors:  David Piñeiro; Javier Fernandez-Chamorro; Rosario Francisco-Velilla; Encarna Martinez-Salas
Journal:  Biomolecules       Date:  2015-04-17

8.  Expression of nm23-H1 and COX-2 in thyroid papillary carcinoma and microcarcinoma.

Authors:  Marija Milkovic Perisa; Bozena Sarcevic; Koraljka Gall Troselj; Kresimir Grsic; Sanda Sitic; Sven Seiwerth
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

Review 9.  [The roles of signal transducer and activator of transcription 3 in tumor metastasis].

Authors:  Lei Gong; Zhihao Wu; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-10

10.  Nucleoside diphosphate kinase (NDPK, NM23, AWD): recent regulatory advances in endocytosis, metastasis, psoriasis, insulin release, fetal erythroid lineage and heart failure; translational medicine exemplified.

Authors:  Anil Mehta; Sandra Orchard
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.